




Searching News Database: Meda AB
HSMN NewsFeed - 9 Jan 2017
Xeris Pharmaceuticals Announces Appointment of Paul R. Edick as President and CEO
Xeris Pharmaceuticals Announces Appointment of Paul R. Edick as President and CEO
HSMN NewsFeed - 2 Aug 2016
Meda Shareholders Representing Approximately 94% of Meda Shares Accept Mylan Offer
Meda Shareholders Representing Approximately 94% of Meda Shares Accept Mylan Offer
HSMN NewsFeed - 30 Aug 2013
Acton Pharmaceuticals, Inc. to Be Acquired by Meda for Up to $200 Million
Acton Pharmaceuticals, Inc. to Be Acquired by Meda for Up to $200 Million
HSMN NewsFeed - 20 Aug 2013
EpiCept Announces Reverse Stock Split and Change of Corporate Name to Immune Pharmaceuticals Inc.
EpiCept Announces Reverse Stock Split and Change of Corporate Name to Immune Pharmaceuticals Inc.
HSMN NewsFeed - 15 Oct 2012
BioDelivery Sciences Announces the Launch of BREAKYL (BEMA Fentanyl) in the E.U.
BioDelivery Sciences Announces the Launch of BREAKYL (BEMA Fentanyl) in the E.U.
HSMN NewsFeed - 6 Sep 2012
Jazz Pharmaceuticals Enters Definitive Agreement to Sell its Women's Health Business to Meda
Jazz Pharmaceuticals Enters Definitive Agreement to Sell its Women's Health Business to Meda
HSMN NewsFeed - 23 Dec 2010
Mylan's Dey Pharma Partners with Meda to Market EpiPen(R) Auto-Injector in Europe
Mylan's Dey Pharma Partners with Meda to Market EpiPen(R) Auto-Injector in Europe
HSMN NewsFeed - 10 May 2010
Valeant Pharmaceuticals Announces Regulatory Approval of Onsolis(TM) in Canada
Valeant Pharmaceuticals Announces Regulatory Approval of Onsolis(TM) in Canada
HSMN NewsFeed - 11 Jan 2010
EpiCept Announces Commercial Licensing Agreement for Ceplene(R) with Meda in Europe and Pacific Rim
EpiCept Announces Commercial Licensing Agreement for Ceplene(R) with Meda in Europe and Pacific Rim
HSMN NewsFeed - 16 Mar 2009
Orexo's Edluar (Sublinox) Receives FDA Approval for the Treatment of Insomnia
Orexo's Edluar (Sublinox) Receives FDA Approval for the Treatment of Insomnia
HSMN NewsFeed - 12 Sep 2008
Valeant Pharmaceuticals Completes Sale of Certain European Operations to Meda AB
Valeant Pharmaceuticals Completes Sale of Certain European Operations to Meda AB
HSMN NewsFeed - 10 Jan 2008
FDA Accepts for Filing the BEMA(TM) Fentanyl NDA from BioDelivery Sciences
FDA Accepts for Filing the BEMA(TM) Fentanyl NDA from BioDelivery Sciences
HSMN NewsFeed - 5 Sep 2007
BDSI Secures U.S. Commercial Partnership for BEMA(TM) Fentanyl with Meda AB
BDSI Secures U.S. Commercial Partnership for BEMA(TM) Fentanyl with Meda AB
HSMN NewsFeed - 20 Jul 2007
Meda Enters the US Market Through the Strategic Acquisition of MedPointe Inc
Meda Enters the US Market Through the Strategic Acquisition of MedPointe Inc
Additional items found! 4

Members Archive contains
4 additional stories matching:
Meda AB
(Password required)
Meda AB
(Password required)